Stockscreener 앱 받기
9.15
8.68%
-0.87
전일 마감가:
$10.02
열려 있는:
$10.03
하루 거래량:
12,721
Relative Volume:
0.38
시가총액:
$38.61M
수익:
-
순이익/손실:
$-26.28M
주가수익비율:
-2.1333
EPS:
-4.2891
순현금흐름:
$-12.39M
1주 성능:
-14.88%
1개월 성능:
+15.09%
6개월 성능:
-52.34%
1년 성능:
-85.59%
1일 변동 폭
$9.15
$10.17
1주일 범위
$9.15
$12.03
52주 변동 폭
$4.1353
$71.00
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
명칭
Tevogen Bio Holdings Inc
전화
646-807-8832
주소
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
9.15 | 42.28M | 0 | -26.28M | -12.39M | -4.2891 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-04 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-03-04 | 개시 | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc 주식(TVGN)의 최신 뉴스
Tevogen Bio Holdings Inc. Q4 2025 Earnings: Narrower Loss Beats Expectations as Development Progress ContinuesROIC Trend Report - newsline.com
Tevogen Bio (TVGN) registers 375,000 shares for resale by Patel Family - Stock Titan
Tevogen Bio Q4 2025 Earnings: EPS Surprise Beat Amid Ongoing Operational ChallengesProfit Guidance Range - newsline.com
Number of shareholders of Tevogen Bio Holdings Inc. – NASDAQ:TVGNW - TradingView
Tevogen Bio Holdings Inc. Announces William Keane as Interim Head of New Healthcare Services Initiative, Exploring MSO and CRO Acquisitions - Quiver Quantitative
Tevogen weighs $100M in potential MSO, CRO revenue with new unit - Stock Titan
TVGN Q4 2025 Earnings: Narrowed Loss Per Share Exceeds Expectations, Shares RisePost-Earnings Reaction - newsline.com
Tevogen Bio Q4 2025 Earnings: EPS Surprise Beats Estimates Despite No Revenue, Shares RiseAnalyst Consensus Shift - newsline.com
TVGN Q4 2025 Earnings: Narrowed Loss Beats Expectations as Stock SurgesSlow Growth Warning - newsline.com
TEVOGEN BIO HOLDINGS INC (TVGN) Stock Chart - ChartMill
Why Is Tevogen Bio Holdings Inc. (TVGNW) Stock Down Today? - Meyka
Tevogen Bio Holdings Inc. (TVGN) Q4 2025 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline AdvancesRevenue Beat Analysis - newsline.com
TVGN Q4 2025 Earnings: Narrower Loss Surprises as Tevogen Focuses on Pipeline ExecutionEarnings Cycle Outlook - newsline.com
Tevogen Shares Drop After $100 Million Revenue Target; Deal Risk Eyed - Bez Kabli
TVGN News | TEVOGEN BIO HOLDINGS INC (NASDAQ:TVGN) - ChartMill
Tevogen Bio Holdings Inc. Outlines Strategic Acquisition Initiatives Aiming for $100 Million in Annual Revenue - Quiver Quantitative
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 ... - Caledonian Record
Tevogen outlines biotech, AI and healthcare services vision - Stock Titan
Tevogen Bio Inc: Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue - FinanzNachrichten.de
Tevogen Bio Warrant (TVGNW) Holds at $0.04 with Modest UptickDividend Growth Stocks - newsline.com
Tevogen Bio Holdings (TVGN) Slides 10.5% as Selling Pressure IntensifiesMomentum Breakout Ideas - newsline.com
Tevogen Bio Warrants Hold Flat at $0.04 as Support and Resistance ConvergePrice Surge Stocks - The Legal Advocate
Tevogen Bio Holdings Q4 2025 Earnings: Narrower-than-Expected Loss Fails to Lift SharesInstitutional Grade Picks - Newser
TVGN Q4 2025 Earnings: Narrower-Than-Expected Loss but No Revenue Growth Keeps Stock Under PressureConsensus Beat Rate - The Legal Advocate
Tevogen Bio Holdings Warrant (TVGNW) Stalls at $0.04 as Trading Remains FlatMACD Signal Stocks - Newser
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization - The Manila Times
Tevogen Bio Holdings Inc. (TVGN) Stock: Jumps 11.74% on Potential Healthcare Expansion Deal - parameter.io
Tevogen Also Considering Other Transactions With a Focus on Life Sciences and Healthcare-Related Businesses - Moomoo
Tevogen Bio Holdings Inc. Signs Non-Binding Letter of Intent to Explore Strategic Healthcare Transaction - Quiver Quantitative
Tevogen explores MSO deal that could pave path to $100M - Stock Titan
Tevogen Bio Holdings Company Profile & Introduction - Moomoo
Letter to Shareholders from CEO Dr. Ryan Saadi - Sahm
TVGN Shares Updates on Operational Improvements and Strategic Go - GuruFocus
Tevogen reports reduced operating losses in 2025 and Q1 2026 By Investing.com - Investing.com Nigeria
Tevogen reports reduced operating losses in 2025 and Q1 2026 - Investing.com
Tevogen ‘working towards’ aligning long-term incentives, performance milestones - TipRanks
Tevogen Bio Holdings Inc. Reports Significant Operational Improvements and Strategic Growth Initiatives - Quiver Quantitative
Tevogen CEO details 51% loss cut and pursuit of new deals - Stock Titan
Tevogen Bio Holdings Inc. 1Q 2026: Revenue $0 Net loss $(5.45)M — 10-Q Summary - TradingView
Tevogen Bio (TVGN) Q1 loss narrows but cash, Nasdaq listing pressures grow - Stock Titan
Tevogen Bio Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TVGN Technical Analysis | Trend, Signals & Chart Patterns | TEVOGEN BIO HOLDINGS INC (NASDAQ:TVGN) - ChartMill
Number of shareholders of Tevogen Bio Holdings Inc. – NASDAQ:TVGN - TradingView
Tevogen (TVGN) Stock: Secures Fresh Capital to Advance Precision Healthcare Platform - parameter.io
Tevogen announces $3 million private investment at $8 per share, a 14% premium from latest market close - marketscreener.com
Tevogen Bio Holdings Inc. Secures $3 Million PIPE Financing from The Patel Family, LLP - Quiver Quantitative
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest ... - Caledonian Record
Existing backer pays 14% premium in Tevogen’s new $3M cash raise - Stock Titan
TradingKey - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
The growth story Tevogen (TVGNW) is not telling investors (-2.53%) 2026-05-08Blue Chip Stocks - Newser
Tevogen Bio Holdings Inc (TVGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tevogen Bio Holdings Inc 주식 (TVGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Flomenberg Neal | See Remarks |
Mar 13 '26 |
Sale |
6.40 |
501 |
3,206 |
76,940 |
| Flomenberg Neal | See Remarks |
Mar 10 '26 |
Sale |
7.75 |
19 |
147 |
77,893 |
1.27%
1.43%
자본화:
|
볼륨(24시간):